Role of Angptl4 in vascular permeability and inflammation

Inflammation Research

Volumn 63, Issue 1, 2014, Pages 13-22

  Guo, Liang ^a   Li, Shao Ying ^b   Ji, Fu Yun ^a   Zhao, Yun Feng ^c   Zhong, Yu ^d   Lv, Xue Jun ^a   Wu, Xue Ling ^a   Qian, Gui Sheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

^c Pudong New Area Gongli Hospital   (China)

^d No 324 Hospital of Chengdu Military Region   (China)

Author keywords

Angiogenesis; Angptl4; Inflammation; Vascular permeability

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN; PROTEIN ANGPTL4; UNCLASSIFIED DRUG;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; DIABETIC RETINOPATHY; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; KIDNEY DISEASE; METASTASIS; NEOPLASM; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW;

ANGIOPOIETINS; ANIMALS; CAPILLARY PERMEABILITY; HUMANS; INFLAMMATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REPERFUSION INJURY;

EID: 84891874511     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0678-0     Document Type: Review

References (56)

1. Goddard LM, Iruela-Arispe ML. Cellular and molecular regulation of vascular permeability. Thromb Haemost. 2013;109:407-15.
2. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, et al. Pericytes regulate the blood-brain barrier. Nature. 2010;468:557-61.
3. Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010;468:562-6.
4. Mehta D. Signalling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86:279-367.
5. Dvorak AM, Feng D. The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J Histochem Cytochem. 2001;49:419-32.
6. Miyawaki-Shimizu K, Predescu D, Shimizu J, Broman M, Predescu S, Malik AB. siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway. Am J Physiol Lung Cell Mol Physiol. 2006;290:L405-13.
7. Thennes T, Mehta D. Heterotrimeric G proteins, focal adhesion kinase, and endothelial barrier function. Microvasc Res. 2012;83:31-44.
8. Sun Z, Li X, Massena S, Kutschera S, Padhan N, Gualandi L, et al. VEGFR2 induces c-Src signalling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med. 2012;209:1363-77.
9. Thibeault S, Rautureau Y, Oubaha M, Faubert D, Wilkes BC, Delisle C, et al. S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. Mol Cell. 2010;39:468-76.
10. Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G, et al. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem. 2007;282:23910-8. (Pubitemid 47328051)
11. Yao Q, Shin MK, Jun JC, Hernandez KL, Aggarwal NR, Mock FR, et al. Effect of chronic intermittment hypoxia on triglyceride uptake in different tissues. J Lipid Res. 2013;54:1058-65.
12. Zhu PC, GOH YY, Alison HF. Angiopoietin-like 4: a decade of research. Biosci Rep. 2011;32:211-9.
13. Valenzuela DM, Griffiths JA, Rojas J, Aldrich TH, Jones PF, Zhou H, et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA. 1996;96:1904-9.
14. Wiesner G, Morash BA, Ur E, Wilkinson M. Food restriction regulates adipose-specific cytokines in pituitary gland but not in hypothalamus. J Endocrinol. 2004;180:R1-6.
15. Koliwad SK, Kuo T, Shipp LE, Gray NE, Backhed F, Wang JC, et al. Angiopoietin-like 4(ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J. BiolChem. 2009;284:25593-601.
16. Kersten S, Mandard S, Tan NS, Escher P, Metzger D, Chambon P, et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferators-activated receptor target gene. J Biol Chem. 2000;275:28488-93.
17. Kersten S, Lichtenstein L, Steenbergen E, Mudde K, Hendriks HJ, Hesselink MK, et al. Caloric restriction and exercises increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol. 2009;29:969-74.
18. Padua D, Zhang XHF, Wang Q, Nadal C, Gerald WL, Gomis RR, et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 2008;133:66-77. (Pubitemid 351442989)
19. Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med. 2011;17:117-22.
20. Galaup A, Cazes A, Le Jan S, Phlippe J, Connault E, CozE Le, et al. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA. 2006;103:18721-6. (Pubitemid 44913477)
21. Huang RL, Teo Z, Chong HC, Zhu P, Tan MJ, Tan CK, et al. ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters. Blood. 2011;118:3990-4002.
22. Katanasaka Y, Kodera Y, Kitamura Y, Morimoto T, Tamura T, Koizumi F. Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma. Mol Cancer. 2013;25:12-31.
23. Perdiguero EG, Galaup A, Durand M, Teillon J, Phillippe J, Valenzuela DM, et al. Alteration of developmental and pathological retinal angiogenesis in angptl4-deficient mice. J Biol Chem. 2011;286:36841-51.
24. Mandard S, Zandbergen F, Tan NS, Escher P, Patsouris D, Koenig W, et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem. 2004;279:34411-20. (Pubitemid 39318067)
25. Ge H, Yang G, Huang L, Motola DL, Pourbahrami T, Li C. Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J Biol Chem. 2004;279:2038-45. (Pubitemid 38084475)
26. Lei X, Shi F, Basu D, Huq A, Routhier S, Day R, et al. Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity. J Biol Chem. 2011;286:15747-56.
27. Mandard S, Zandbergen F, Tan NS, Escher P, Patsouris D, Koenig W, et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem. 2004;279:34411-20. (Pubitemid 39318067)
28. Stapleton CM, Joo JH, Kim Y-S, Liao G, Panettieri RA Jr, Jetten AM. Induction of ANGPTL4 expression in human airway smooth muscle cells by PMA through activation of PKC and MAPK pathways. Exp Cell Res. 2010;316:507-16.
29. Yang YH, Wang Y, Lam KS, Yau MH, Cheng KK, Zhang J, et al. Supression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4. Arterioscler Thromb Vasc Biol. 2008;28:835-40. (Pubitemid 351544096)
30. Ito Y, Olike Y, Yasunaga K, Hamada K, Miyata K, Matsumoto SI, et al. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res. 2003;63:6651-7. (Pubitemid 37322943)
31. Hutchings H, Ortega N, Plouet J. Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J. 2003;17:1520-2.
32. Okochi-Takada E, Hattori N, Tsukamoto T, Miyamoto K, Ando T, Ito S, et al. ANGPTL4 is a secreted tumor suppressor that inhibits angiogenesis. Oncogene. 2013; 174 [Epub ahead of print].
33. Le Jan S, Amy C, Cazes A, Monnot C, Lamande N, Favier J, et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol. 2003;162:1521-8. (Pubitemid 36512834)
34. Goh YY, Pal M, Chong HC, Zhu P, Tan MJ, Punugu L, et al. Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J Biol Chem. 2010;285:32999-3009.
35. Galaup A, Gomez E, Souktani R, Durand M, Cazes A, Monnot C, et al. Protection aganist myocardial infarction and no-reflow through preservation of vascular integrity by angptl4. Circulation. 2012;125:140-9.
36. Quintero P, Gonzalez-Muniesa P, Martinez JA. Influence of different oxygen supply on metabolic markers and gene response in murine adipocytes. J Biol Requl Homeost Agents. 2012;26:379-88.
37. Lichtenstein L, Mattijssen F, de Wi NJ, Georgiadi A, Hooiveld GJ, van der Meer R, et al. ANGPTL4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab. 2010;12:580-92.
38. Brown R, Imran SA, Wilkinson M. Lipopolysaccharide (LPS) stimulates adipokine and socs3 gene expression in mouse brain and pituitary gland in vivo, and in N-1 hypothalamic neurons in vitro. J Neuroimmunol. 2009;209:96-103.
39. Lu B, Moser A, Shigenaga JK, Grunfeld C, Feingold KR. The acute phase response stimulates the expression of angiopoietin like protein 4. Biochem Biophys Res Commun. 2010;391:1737-41.
40. Rummel C, Inoue W, Sachot C, Poole S, Hubschle T, Luheshi GN. Selective contribution of interleukin-6 and leptin to brain inflammatory signals induced by systemic LPS injection in mice. J Comp Neurol. 2008;511:373-95.
41. 2 ratio and confers anoikis resistance to tumors. Cancer Cell. 2011;19:401-15.
42. Nakayama T, Hirakawa H, Shibata K, Nazneen A, Abe K, Naqayasu T, et al. Expression of angiopoietin-like 4(ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis. Oncol Rep. 2011;25:929-35.
43. Shibata K, Nakayama T, Hirakama H, Hidaka S, Naqayasu T. Clinicopathological significance of angiopoietin-like protein 4 expression in oesophageal squamous cell carcinoma. J Clin Pathol. 2010;63:1054-8.
44. Ma T, Jham BC, Hu J, Friedman ER, Basile JR, Molinolo A, et al. Viral G protein-coupled receptor up-regulates angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma. PNAS. 2010;107:14363-8.
45. Reiser J. Filtering new facts about kidney disease. Nat Med. 2011;17:44-5.
46. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835-70. (Pubitemid 36828927)
47. Goh YY, Pal M, Chong HC, Zhu P, Tan MJ, Punugu L, et al. Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration. Am J Pathol. 2010;177:2791-803.
48. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med. 2011;62:361-80.
49. Lichtenstein L, Berbée JF, van Dijk SJ, van Dijk KW, Bensadoun A, Kema IP, et al. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol. 2007;27:2420-7. (Pubitemid 350203959)
50. Adachi H, Fujiwara Y, Kondo T, Nishikawa T, Ogawa R. Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. Biochem Biophys Res Commun. 2009;379:806-11.
51. Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs HH, et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet. 2007;39:513-6. (Pubitemid 46514768)
52. Folsom AR, Peacock JM, Demerath E, Boerwinkle E. Variation in ANGPTL4 and risk of coronary heart disease: the atherosclerosis risk in communities study. Metabolism. 2008;57:1591-6.
53. Jonker JT, Smit JW, Hammer S, Snel M, van der Meer RW, Lamb HJ, et al. Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes. Am J Clin Nutr. 2013;97:255-60.
54. Xu A, Lam MC, Chan KW, Wang Y, Zhang J. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci USA. 2005;102:6086-91. (Pubitemid 40594259)
55. Yokouchi H, Eto K, Nishimura W, Takeda N, Kaburagi Y, Yamamoto S, et al. Angiopoietin-like protein 4 (ANGPTL4) is induced by high glucose in retinal pigment epithelial cells and exhibits potent angiogenic activity on retinal endothelial cells. Acta Ophthalmol. 2013;91:e289-97.
56. Bouleti C, Mathivet T, Coqueran B, Serfaty JM, Lesaqe M, Berland E, et al. Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke. Eur Heart J. 2013; [Epub ahead of print].